Ondansetron FDA Link Generic

A competitive serotonin type 3 receptor antagonist. It is effective in the treatment of nausea and vomiting caused by cytotoxic chemotherapy drugs, including cisplatin, and has reported anxiolytic and neuroleptic properties.

Also Known As:

Zofran; SN 307; GR-38032F; GR38032F; Ondansetron Hydrochloride; Ondansetron Monohydrochloride; Ondansetron Monohydrochloride Dihydrate; Ondansetron, (+,-)-Isomer; Ondansetron, (R)-Isomer; Ondansetron, (S)-Isomer; SN-307; Dihydrate, Ondansetron Monohydrochloride; GR 38032F; Hydrochloride, Ondansetron; Monohydrochloride Dihydrate, Ondansetron; Monohydrochloride, Ondansetron; SN307; 4H-Carbazol-4-one, 1,2,3,9- tetrahydro- 9- methyl- 3- ((2- methyl- 1H- imidazol- 1- yl)methyl)-

Pharmalogical Action Categories:

Anti-Anxiety Agents
Antiemetics
Antipruritics
Antipsychotic Agents
Serotonin Antagonists

-

Heterocyclic Compounds: 25

-

1-Ring Heterocyclic Compounds

-

Azoles: 243

-

Imidazoles: 97

*

Ondansetron: 1435

-

2-Ring Heterocyclic Compounds

-

Indoles: 70

-

Carbazoles: 5

*

Ondansetron: 1435

-

3-Ring Heterocyclic Compounds

-

Carbazoles: 5

*

Ondansetron: 1435

Create Custom RSS News Feed:
	Ondansetron (Zofran)

Aceto Pharma Inc Product Research

Products